ERTS Wealth Advisors’s CVS Health CVS Stock Holding History

ERTS Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-216	Closed	-$14K	–	141
2018 Q4	$14K	Buy	+216	New	+$16.1K	0.01%	231

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ERTS Wealth Advisors's CVS Position: Q1 2019 in Review

ERTS Wealth Advisors sold out of CVS Health (CVS) in Q1 2019, closing a stake of 216 shares — an estimated $14K sold.

ERTS Wealth Advisors first reported a position in CVS in Q4 2018 and held it in 1 quarter. The position peaked at $14K in Q4 2018. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

ERTS Wealth Advisors reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
ERTS Wealth Advisors sold 216 CVS Health shares in Q1 2019, an estimated $14K.
ERTS Wealth Advisors first reported a position in CVS Health in Q4 2018 and held it in 1 quarter.
ERTS Wealth Advisors's CVS Health position peaked at $14K in Q4 2018.
1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on ERTS Wealth Advisors's 13F filing for Q1 2019, filed 15 May 2019.